Article PDF
Use our pre-submission checklist
Avoid common mistakes on your manuscript.
Rights and permissions
About this article
Cite this article
Patienten profitieren von frühzeitiger und anhaltender Therapie mit Zoledronat. Best Practice Onkologie 6, 25 (2011). https://doi.org/10.1007/BF03359867
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03359867